Clinical trial
RISE: Rapid Recovery Through Integrated Substance Use Treatment and Written Exposure for PTSD
NCT07903753 is registered in ClinicalTrials.gov with VA Office of Research and Development as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing
Registry record
As filed in ClinicalTrials.gov.
- Title
- RISE: Rapid Recovery Through Integrated Substance Use Treatment and Written Exposure for PTSD
- Lead sponsor
- VA Office of Research and Development
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- August 1, 2028
- Completion date
- July 31, 2030
- Enrollment
- 30 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
Arms
As registered; 2 arms.
-
RISE
An intervention that integrates Written Exposure Therapy (WET) for PTSD with core components of Cognitive Behavioral Therapy for Substance Use Disorder (CBT-SUD), delivered over six weekly, 90-minute individual sessions.
-
CBT-SUD
An evidence-based, individually delivered Cognitive Behavioral Therapy for Substance Use Disorder, delivered over six weekly, 90-minute sessions matched to RISE for total clinical contact time.
Primary endpoints
Registered primary outcome measures; 6 primary.
-
Feasibility: Participant Recruitment
Rate of eligible screened Veterans and enrollment rate, used as an indicator of the reach and accessibility of RISE.
-
Feasibility: Study Retention
Proportion of enrolled participants retained through study completion.
-
Feasibility: Number of Sessions Attended
Average number of treatment sessions attended by participants in each arm, used as a behavioral indicator of treatment engagement.
-
Feasibility: Treatment Completion
Proportion of participants who complete all six treatment sessions, used as a behavioral indicator of feasibility.
-
Feasibility: Study Withdrawals
Number and proportion of participants who withdraw from the study prior to treatment completion.
+1 more primary endpoint
Lead sponsor's other trials
VA Office of Research and Development, most recent start first.
+1,767 more trials See the organization page
Similar trials
Same condition (Stress Disorders, Post-Traumatic) and phase, most recent start first.
+1,634 more trials See the condition page